Premium
Cardiovascular profile of loratadine
Author(s) -
Hey J. A.,
Affrime M.,
Cobert B.,
Kreutner W.,
Cuss F. M.
Publication year - 1999
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1046/j.1365-2222.1999.0290s3197.x
Subject(s) - loratadine , medicine , adverse effect , safety profile , intensive care medicine , cardiology , pharmacology
The extremely low reporting rate of cardiovascular adverse events for loratadine, the possible preferential use of loratadine in patients with pre‐existing cardiovascular disorders, and the impressive lack of cardiovascular effects at extremely high concentrations in clinical and preclinical studies demonstrate the very safe cardiovascular profile of loratadine.